Perception of Spanish nephrologists on an old unsolved problem : Pruritus associated with chronic kidney disease (CKD-aP)
Copyright © 2022 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved..
INTRODUCTION: Pruritus associated with chronic kidney disease is defined as the sensation of itching, in people with chronic kidney disease, in a one area or all over the body that causes the need to scratch, after having ruled out other dermatological or systemic causes. It is an old and known problem whose prevalence has been able to decrease with the improvement of dialytic techniques but which still persists and is underdiagnosed.
OBJECTIVES: The objective of this study was to analyse the current perception of nephrologists about this problem that influences the quality of life of people with chronic kidney disease through a survey.
RESULTS: 135 nephrologists, most of them engaged in haemodialysis, participated. 86% considered that pruritus associated with chronic kidney disease is still a problem today that affects the quality of life. Most nephrologists believe that the main pathophysiological cause is uremic toxins (60%) and only 16% believe that it is due to the dysregulation of the opioid system/endorphins-dynorphins. Only 16% comment that the prevalence of pruritus in their centre is greater than 20%. 40% believe that the diagnosis is made because it is manifested by the patient and only 27% because it is asked by the doctor. Moreover, it is not usual to use scales to measure it or the codification in the medical records. The main treatment used is antihistamines (96%), followed by moisturizers/anaesthetics (93%) and modification of the dialysis regimen (70%).
CONCLUSIONS: Pruritus associated with chronic kidney disease is still a current problem, it is underdiagnosed, not codified and with a lack of indicated, effective and safe treatments. Nephrologists do not know its real prevalence and the different pathophysiological mechanisms involved in its development. Many therapeutic options are used with very variable results, ignoring their efficacy and applicability at the present time. The new emerging kappa-opioid-receptor agonist agents offer us an opportunity to reevaluate this age-old problem and improve the quality of life for our patients with chronic kidney disease.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Nefrologia - 43(2023), 1 vom: 22. Jan., Seite 102-110 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Goicoechea, Marian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Analgesics, Opioid |
|---|
| Anmerkungen: |
Date Completed 12.06.2023 Date Revised 30.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.nefroe.2023.03.012 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355730421 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355730421 | ||
| 003 | DE-627 | ||
| 005 | 20240131231840.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.nefroe.2023.03.012 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1276.xml |
| 035 | |a (DE-627)NLM355730421 | ||
| 035 | |a (NLM)37069038 | ||
| 035 | |a (PII)S2013-2514(23)00066-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Goicoechea, Marian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Perception of Spanish nephrologists on an old unsolved problem |b Pruritus associated with chronic kidney disease (CKD-aP) |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.06.2023 | ||
| 500 | |a Date Revised 30.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a INTRODUCTION: Pruritus associated with chronic kidney disease is defined as the sensation of itching, in people with chronic kidney disease, in a one area or all over the body that causes the need to scratch, after having ruled out other dermatological or systemic causes. It is an old and known problem whose prevalence has been able to decrease with the improvement of dialytic techniques but which still persists and is underdiagnosed | ||
| 520 | |a OBJECTIVES: The objective of this study was to analyse the current perception of nephrologists about this problem that influences the quality of life of people with chronic kidney disease through a survey | ||
| 520 | |a RESULTS: 135 nephrologists, most of them engaged in haemodialysis, participated. 86% considered that pruritus associated with chronic kidney disease is still a problem today that affects the quality of life. Most nephrologists believe that the main pathophysiological cause is uremic toxins (60%) and only 16% believe that it is due to the dysregulation of the opioid system/endorphins-dynorphins. Only 16% comment that the prevalence of pruritus in their centre is greater than 20%. 40% believe that the diagnosis is made because it is manifested by the patient and only 27% because it is asked by the doctor. Moreover, it is not usual to use scales to measure it or the codification in the medical records. The main treatment used is antihistamines (96%), followed by moisturizers/anaesthetics (93%) and modification of the dialysis regimen (70%) | ||
| 520 | |a CONCLUSIONS: Pruritus associated with chronic kidney disease is still a current problem, it is underdiagnosed, not codified and with a lack of indicated, effective and safe treatments. Nephrologists do not know its real prevalence and the different pathophysiological mechanisms involved in its development. Many therapeutic options are used with very variable results, ignoring their efficacy and applicability at the present time. The new emerging kappa-opioid-receptor agonist agents offer us an opportunity to reevaluate this age-old problem and improve the quality of life for our patients with chronic kidney disease | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Chronic kidney disease | |
| 650 | 4 | |a Dialysis | |
| 650 | 4 | |a Diálisis | |
| 650 | 4 | |a Enfermedad renal crónica | |
| 650 | 4 | |a Prurito | |
| 650 | 4 | |a Pruritus | |
| 650 | 4 | |a Tratamientos | |
| 650 | 4 | |a Treatments | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 700 | 1 | |a Arenas-Jimenez, María Dolores |e verfasserin |4 aut | |
| 700 | 1 | |a Areste, Nuria |e verfasserin |4 aut | |
| 700 | 1 | |a Perez-Morales, Rosa Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Esteve, Vicens |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez-Alvarez, Emilio |e verfasserin |4 aut | |
| 700 | 1 | |a Alcalde Bezhold, Guillermo |e verfasserin |4 aut | |
| 700 | 1 | |a Blanco, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez-Villanueva, Rafael |e verfasserin |4 aut | |
| 700 | 1 | |a Molina, Pablo |e verfasserin |4 aut | |
| 700 | 1 | |a Ojeda, Raquel |e verfasserin |4 aut | |
| 700 | 1 | |a Prieto-Velasco, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Manuel Buades, Juan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nefrologia |d 2018 |g 43(2023), 1 vom: 22. Jan., Seite 102-110 |w (DE-627)NLM270991409 |x 2013-2514 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2023 |g number:1 |g day:22 |g month:01 |g pages:102-110 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nefroe.2023.03.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2023 |e 1 |b 22 |c 01 |h 102-110 | ||